Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how
Abstract Purpose The endogenous hypercortisolism that characterizes Cushing’s syndrome (CS) is associated with a state of hypercoagulability that significantly increases the risk of thromboembolic disease, especially, venous events. Despite this certainty, there is no consensus on the best thrombopr...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-07-01
|
| Series: | Thrombosis Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12959-023-00515-1 |
| _version_ | 1797784417128677376 |
|---|---|
| author | Valentim Lopes Olinda Marques Adriana De Sousa Lages |
| author_facet | Valentim Lopes Olinda Marques Adriana De Sousa Lages |
| author_sort | Valentim Lopes |
| collection | DOAJ |
| description | Abstract Purpose The endogenous hypercortisolism that characterizes Cushing’s syndrome (CS) is associated with a state of hypercoagulability that significantly increases the risk of thromboembolic disease, especially, venous events. Despite this certainty, there is no consensus on the best thromboprophylaxis strategy (TPS) for these patients. Our aim was to summarize the published data about different thromboprophylaxis strategies, and to review available clinical tools assisting thromboprophylaxis decision making. Methods Narrative review of thromboprophylaxis strategies in patients with Cushing’s syndrome. A search was carried out on PubMed, Scopus and EBSCO until November 14th, 2022, and articles were selected based on their relevance and excluded in case of redundant content. Results Literature is scarce regarding thromboprophylaxis strategies to be adopted in the context of endogenous hypercortisolism, most often being a case-by-case decision according to the centre expertise. Only three retrospective studies, with a small number of patients enrolled, evaluated the use of hypocoagulation for the thromboprophylaxis of patients with CS in the post-operative period of transsphenoidal surgery and/or adrenalectomy, but all of them with favourable results. The use of low molecular weight heparin is the most frequent option as TPS in CS context. There are numerous venous thromboembolism risk assessment scores validated for different medical purposes, but just one specifically developed for CS, that must be validated to ensure solid recommendations in this context. The use of preoperative medical therapy is not routinely recommended to decrease the risk of postoperative venous thromboembolic events. The peak of venous thromboembolic events occurs in the first three months post-surgery. Conclusion The need to hypocoagulate CS patients, mainly in the post-operative period of a transsphenoidal surgery or an adrenalectomy, is undoubtable, especially in patients with an elevated risk of venous thromboembolic events, but the precise duration and the hypocoagulation regimen to institute is yet to be determined with prospective studies. |
| first_indexed | 2024-03-13T00:40:33Z |
| format | Article |
| id | doaj.art-575654ee4e45484ba62f81d167d68a93 |
| institution | Directory Open Access Journal |
| issn | 1477-9560 |
| language | English |
| last_indexed | 2024-03-13T00:40:33Z |
| publishDate | 2023-07-01 |
| publisher | BMC |
| record_format | Article |
| series | Thrombosis Journal |
| spelling | doaj.art-575654ee4e45484ba62f81d167d68a932023-07-09T11:21:52ZengBMCThrombosis Journal1477-95602023-07-0121111010.1186/s12959-023-00515-1Preventive strategies for hypercoagulation in Cushing’s syndrome: when and howValentim Lopes0Olinda Marques1Adriana De Sousa Lages2Endocrinology Department of Hospital of BragaEndocrinology Department of Hospital of BragaEndocrinology Department of Hospital of BragaAbstract Purpose The endogenous hypercortisolism that characterizes Cushing’s syndrome (CS) is associated with a state of hypercoagulability that significantly increases the risk of thromboembolic disease, especially, venous events. Despite this certainty, there is no consensus on the best thromboprophylaxis strategy (TPS) for these patients. Our aim was to summarize the published data about different thromboprophylaxis strategies, and to review available clinical tools assisting thromboprophylaxis decision making. Methods Narrative review of thromboprophylaxis strategies in patients with Cushing’s syndrome. A search was carried out on PubMed, Scopus and EBSCO until November 14th, 2022, and articles were selected based on their relevance and excluded in case of redundant content. Results Literature is scarce regarding thromboprophylaxis strategies to be adopted in the context of endogenous hypercortisolism, most often being a case-by-case decision according to the centre expertise. Only three retrospective studies, with a small number of patients enrolled, evaluated the use of hypocoagulation for the thromboprophylaxis of patients with CS in the post-operative period of transsphenoidal surgery and/or adrenalectomy, but all of them with favourable results. The use of low molecular weight heparin is the most frequent option as TPS in CS context. There are numerous venous thromboembolism risk assessment scores validated for different medical purposes, but just one specifically developed for CS, that must be validated to ensure solid recommendations in this context. The use of preoperative medical therapy is not routinely recommended to decrease the risk of postoperative venous thromboembolic events. The peak of venous thromboembolic events occurs in the first three months post-surgery. Conclusion The need to hypocoagulate CS patients, mainly in the post-operative period of a transsphenoidal surgery or an adrenalectomy, is undoubtable, especially in patients with an elevated risk of venous thromboembolic events, but the precise duration and the hypocoagulation regimen to institute is yet to be determined with prospective studies.https://doi.org/10.1186/s12959-023-00515-1ThromboprophylaxisHypercortisolismCushing’s syndromeLow molecular weight heparin |
| spellingShingle | Valentim Lopes Olinda Marques Adriana De Sousa Lages Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how Thrombosis Journal Thromboprophylaxis Hypercortisolism Cushing’s syndrome Low molecular weight heparin |
| title | Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how |
| title_full | Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how |
| title_fullStr | Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how |
| title_full_unstemmed | Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how |
| title_short | Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how |
| title_sort | preventive strategies for hypercoagulation in cushing s syndrome when and how |
| topic | Thromboprophylaxis Hypercortisolism Cushing’s syndrome Low molecular weight heparin |
| url | https://doi.org/10.1186/s12959-023-00515-1 |
| work_keys_str_mv | AT valentimlopes preventivestrategiesforhypercoagulationincushingssyndromewhenandhow AT olindamarques preventivestrategiesforhypercoagulationincushingssyndromewhenandhow AT adrianadesousalages preventivestrategiesforhypercoagulationincushingssyndromewhenandhow |